Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

Cited In for PubMed (Select 15192448)

1.

Pharmacology of manipulating lean body mass.

Sepulveda PV, Bush ED, Baar K.

Clin Exp Pharmacol Physiol. 2015 Jan;42(1):1-13. doi: 10.1111/1440-1681.12320.

2.

METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-κB signaling pathway.

Huang J, Hsu YH, Mo C, Abreu E, Kiel DP, Bonewald LF, Brotto M, Karasik D.

J Bone Miner Res. 2014 Jul;29(7):1531-40. doi: 10.1002/jbmr.2200.

PMID:
24677265
3.

The effect of relaxin on the musculoskeletal system.

Dehghan F, Haerian BS, Muniandy S, Yusof A, Dragoo JL, Salleh N.

Scand J Med Sci Sports. 2013 Nov 28. doi: 10.1111/sms.12149. [Epub ahead of print]

4.

Isolation, characterization, and molecular regulation of muscle stem cells.

Fukada S, Ma Y, Ohtani T, Watanabe Y, Murakami S, Yamaguchi M.

Front Physiol. 2013 Nov 12;4:317. doi: 10.3389/fphys.2013.00317. eCollection 2013. Review.

5.

Obesity and diabetes as accelerators of functional decline: can lifestyle interventions maintain functional status in high risk older adults?

Anton SD, Karabetian C, Naugle K, Buford TW.

Exp Gerontol. 2013 Sep;48(9):888-97. doi: 10.1016/j.exger.2013.06.007. Epub 2013 Jul 4. Review.

6.

Distinct roles for Ste20-like kinase SLK in muscle function and regeneration.

Storbeck CJ, Al-Zahrani KN, Sriram R, Kawesa S, O'Reilly P, Daniel K, McKay M, Kothary R, Tsilfidis C, Sabourin LA.

Skelet Muscle. 2013 Jul 1;3(1):16. doi: 10.1186/2044-5040-3-16.

7.

Cancer cachexia--pathophysiology and management.

Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A.

J Gastroenterol. 2013 May;48(5):574-94. doi: 10.1007/s00535-013-0787-0. Epub 2013 Mar 20. Review.

8.

Myostatin is a novel tumoral factor that induces cancer cachexia.

Lokireddy S, Wijesoma IW, Bonala S, Wei M, Sze SK, McFarlane C, Kambadur R, Sharma M.

Biochem J. 2012 Aug 15;446(1):23-36. doi: 10.1042/BJ20112024. Erratum in: Biochem J. 2015 Feb 15;466(1):201.

9.

Sexually dimorphic effect of aging on skeletal muscle protein synthesis.

Smith GI, Reeds DN, Hall AM, Chambers KT, Finck BN, Mittendorfer B.

Biol Sex Differ. 2012 May 23;3(1):11. doi: 10.1186/2042-6410-3-11.

10.

Novel tyrosine phosphorylation sites in rat skeletal muscle revealed by phosphopeptide enrichment and HPLC-ESI-MS/MS.

Zhang X, Højlund K, Luo M, Meyer C, Geetha T, Yi Z.

J Proteomics. 2012 Jul 16;75(13):4017-26. doi: 10.1016/j.jprot.2012.05.009. Epub 2012 May 18.

11.

The intersection between aging and cardiovascular disease.

North BJ, Sinclair DA.

Circ Res. 2012 Apr 13;110(8):1097-108. doi: 10.1161/CIRCRESAHA.111.246876. Review.

12.

Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients.

Lunetta C, Serafini M, Prelle A, Magni P, Dozio E, Ruscica M, Sassone J, Colciago C, Moggio M, Corbo M, Silani V.

Muscle Nerve. 2012 Feb;45(2):200-8. doi: 10.1002/mus.22288.

13.
14.

Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology.

Reay DP, Yang M, Watchko JF, Daood M, O'Day TL, Rehman KK, Guttridge DC, Robbins PD, Clemens PR.

Neurobiol Dis. 2011 Sep;43(3):598-608. doi: 10.1016/j.nbd.2011.05.008. Epub 2011 May 23.

15.

Estrogen-related receptor α regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway.

Murray J, Huss JM.

Am J Physiol Cell Physiol. 2011 Sep;301(3):C630-45. doi: 10.1152/ajpcell.00033.2011. Epub 2011 May 11.

16.

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.

Lenk K, Schuler G, Adams V.

J Cachexia Sarcopenia Muscle. 2010 Sep;1(1):9-21. Epub 2010 Oct 26.

17.

Increased energy expenditure and leptin sensitivity account for low fat mass in myostatin-deficient mice.

Choi SJ, Yablonka-Reuveni Z, Kaiyala KJ, Ogimoto K, Schwartz MW, Wisse BE.

Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E1031-7. doi: 10.1152/ajpendo.00656.2010. Epub 2011 Mar 22.

18.

TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy.

Acharyya S, Sharma SM, Cheng AS, Ladner KJ, He W, Kline W, Wang H, Ostrowski MC, Huang TH, Guttridge DC.

PLoS One. 2010 Aug 30;5(8):e12479. doi: 10.1371/journal.pone.0012479.

19.

Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.

Buford TW, Anton SD, Judge AR, Marzetti E, Wohlgemuth SE, Carter CS, Leeuwenburgh C, Pahor M, Manini TM.

Ageing Res Rev. 2010 Oct;9(4):369-83. doi: 10.1016/j.arr.2010.04.004. Epub 2010 May 14. Review.

20.

Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.

Smith IJ, Alamdari N, O'Neal P, Gonnella P, Aversa Z, Hasselgren PO.

Int J Biochem Cell Biol. 2010 May;42(5):701-11. doi: 10.1016/j.biocel.2010.01.006. Epub 2010 Jan 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk